Individualized therapy for childhood acute lymphoblastic leukemia

Author： Raetz Elizabeth A   Bhojwani Deepa   Min Dong-Joon   Carroll William L  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.2, Iss.4, 2005-11, pp. : 349-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Childhood acute lymphoblastic leukemia: Integrating genomics into therapy

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3577-3590

John Wiley & Sons Inc

Access to resources Recommend Favorite

Individualized 6‐mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 53-60

John Wiley & Sons Inc

Access to resources Recommend Favorite

Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: A report from the Children's Oncology Group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 3, 2015-03 ,pp. : 434-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia

By Johansson Bertil   Mertens Fredrik   Mitelman Felix  

Annals of Medicine, Vol. 36, Iss. 7, 2004-11 ,pp. : 492-503

Informa Healthcare

Access to resources Recommend Favorite

Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 955-962

John Wiley & Sons Inc

Access to resources Recommend Favorite